DDInter948 DDInter1416
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
In 2005, the Food and Drug Administration (FDA) withdrew approval for pemoline. In March 2005, Abbott Laboratories (Cylert marketer) had discontinued the production of Cylert arguing economic reasons.
Pemoline {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Peginterferon beta-1a
Pemoline {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Asparaginase Escherichia coli
Pemoline {u} may lead to a major life threatening interaction when taken with {v} Cocaine
Pemoline {u} may lead to a major life threatening interaction when taken with {v} Teriflunomide
Pemoline may cause a moderate interaction that could exacerbate diseases when taken with Peginterferon beta-1a
Pemoline may cause a moderate interaction that could exacerbate diseases when taken with Asparaginase Escherichia coli
Pemoline may lead to a major life threatening interaction when taken with Cocaine
Pemoline may lead to a major life threatening interaction when taken with Teriflunomide